BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 10025408)

  • 1. Crystal structure of the cytoplasmic domain of the type I TGF beta receptor in complex with FKBP12.
    Huse M; Chen YG; Massagué J; Kuriyan J
    Cell; 1999 Feb; 96(3):425-36. PubMed ID: 10025408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the interaction of FKBP12 with the transforming growth factor-beta type I receptor in vivo.
    Okadome T; Oeda E; Saitoh M; Ichijo H; Moses HL; Miyazono K; Kawabata M
    J Biol Chem; 1996 Sep; 271(36):21687-90. PubMed ID: 8702959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel protein distinguishes between quiescent and activated forms of the type I transforming growth factor beta receptor.
    Charng MJ; Zhang D; Kinnunen P; Schneider MD
    J Biol Chem; 1998 Apr; 273(16):9365-8. PubMed ID: 9545258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of TGFbeta receptor inhibition by FKBP12.
    Chen YG; Liu F; Massague J
    EMBO J; 1997 Jul; 16(13):3866-76. PubMed ID: 9233797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The TβR-I pre-helix extension is structurally ordered in the unbound form and its flanking prolines are essential for binding.
    Zuniga JE; Ilangovan U; Mahlawat P; Hinck CS; Huang T; Groppe JC; McEwen DG; Hinck AP
    J Mol Biol; 2011 Sep; 412(4):601-18. PubMed ID: 21821041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The TGF beta receptor activation process: an inhibitor- to substrate-binding switch.
    Huse M; Muir TW; Xu L; Chen YG; Kuriyan J; Massagué J
    Mol Cell; 2001 Sep; 8(3):671-82. PubMed ID: 11583628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunophilin FKBP12 functions as a common inhibitor of the TGF beta family type I receptors.
    Wang T; Li BY; Danielson PD; Shah PC; Rockwell S; Lechleider RJ; Martin J; Manganaro T; Donahoe PK
    Cell; 1996 Aug; 86(3):435-44. PubMed ID: 8756725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis of Smad2 recognition by the Smad anchor for receptor activation.
    Wu G; Chen YG; Ozdamar B; Gyuricza CA; Chong PA; Wrana JL; Massagué J; Shi Y
    Science; 2000 Jan; 287(5450):92-7. PubMed ID: 10615055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of mouse Elf3 C-terminal DNA-binding domain in complex with type II TGF-beta receptor promoter DNA.
    Agarkar VB; Babayeva ND; Wilder PJ; Rizzino A; Tahirov TH
    J Mol Biol; 2010 Mar; 397(1):278-89. PubMed ID: 20079749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A kinase subdomain of transforming growth factor-beta (TGF-beta) type I receptor determines the TGF-beta intracellular signaling specificity.
    Feng XH; Derynck R
    EMBO J; 1997 Jul; 16(13):3912-23. PubMed ID: 9233801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of transforming growth factor-beta signaling by low molecular weight compounds interfering with ATP- or substrate-binding sites of the TGF beta type I receptor kinase.
    Yakymovych I; Engström U; Grimsby S; Heldin CH; Souchelnytskyi S
    Biochemistry; 2002 Sep; 41(36):11000-7. PubMed ID: 12206672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of the ALK (anaplastic lymphoma kinase) catalytic domain.
    Lee CC; Jia Y; Li N; Sun X; Ng K; Ambing E; Gao MY; Hua S; Chen C; Kim S; Michellys PY; Lesley SA; Harris JL; Spraggon G
    Biochem J; 2010 Sep; 430(3):425-37. PubMed ID: 20632993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of the functional binding sites for TGF-beta on the type II receptor leads to suppression of TGF-beta signaling.
    Shimanuki T; Hara T; Furuya T; Imamura T; Miyazono K
    Oncogene; 2007 May; 26(23):3311-20. PubMed ID: 17146441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of Ser165 in TGF-beta type I receptor modulates TGF-beta1-induced cellular responses.
    Souchelnytskyi S; ten Dijke P; Miyazono K; Heldin CH
    EMBO J; 1996 Nov; 15(22):6231-40. PubMed ID: 8947046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of the human TbetaR2 ectodomain--TGF-beta3 complex.
    Hart PJ; Deep S; Taylor AB; Shu Z; Hinck CS; Hinck AP
    Nat Struct Biol; 2002 Mar; 9(3):203-8. PubMed ID: 11850637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of FKBP12.6 in complex with rapamycin.
    Deivanayagam CC; Carson M; Thotakura A; Narayana SV; Chodavarapu RS
    Acta Crystallogr D Biol Crystallogr; 2000 Mar; 56(Pt 3):266-71. PubMed ID: 10713512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 1.1 A crystal structure of human TGF-beta type II receptor ligand binding domain.
    Boesen CC; Radaev S; Motyka SA; Patamawenu A; Sun PD
    Structure; 2002 Jul; 10(7):913-9. PubMed ID: 12121646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive and negative regulation of type II TGF-beta receptor signal transduction by autophosphorylation on multiple serine residues.
    Luo K; Lodish HF
    EMBO J; 1997 Apr; 16(8):1970-81. PubMed ID: 9155023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of transforming growth factor (TGF)-beta Type I and TGF-beta type II receptors in the TGF-beta1-regulated gene expression in pituitary prolactin-secreting lactotropes.
    Sarkar DK; Pastorcic M; De A; Engel M; Moses H; Ghasemzadeh MB
    Endocrinology; 1998 Aug; 139(8):3620-8. PubMed ID: 9681516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of the BMP-2-BRIA ectodomain complex.
    Kirsch T; Sebald W; Dreyer MK
    Nat Struct Biol; 2000 Jun; 7(6):492-6. PubMed ID: 10881198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.